Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes

Results in Pharma Sciences
Fabio SelisStefano Genovese

Abstract

Human glucagon-like peptide-1 (GLP-1) is a physiological gastrointestinal peptide with glucose-dependent insulinotropic effects which is therefore considered an interesting antidiabetic agent. However, after in vivo administration, exogenous GLP-1 does not exert its physiological action due to the combination of rapid proteolytic degradation by ubiquitous dipeptidyldipeptidase IV (DPP IV) enzyme and renal clearance resulting in an extremely short circulating half-life. In this work we describe the conjugation of GLP-1-(7-36)-amide derivatives with polyethylene glycol (PEG) by enzymatic site-specific transglutamination reaction as an approach to reduce both the proteolysis and the renal clearance rates. The compound GLP-1-(7-36)-amide-Q(23)-PEG 20 kDa monopegylated on the single glutamine residue naturally present in position 23 maintained the ability to activate the GLP-1 receptor expressed in the rat β-cell line RIN-m5F with nanomolar potency along with an increased in vitro resistance to DDP IV and a circulating half-life of about 12 h after subcutaneous administration in rats. These properties enabled GLP-(7-36)-amide-Q(23)-PEG 20 kDa to exert a glucose-stabilizing effect for a period as long as 8 h, as demonstrated by a sin...Continue Reading

Citations

Oct 18, 2019·Current Drug Delivery·Di ZhangYueze Liu
Dec 28, 2019·World Journal of Microbiology & Biotechnology·Lovaine DuarteMarco Antônio Záchia Ayub
Feb 5, 2021·International Journal of Biological Macromolecules·Jiaman TengYantao Chen
Jun 9, 2020·Bioconjugate Chemistry·Caroline TsaoShaoyi Jiang
Aug 17, 2019·Journal of the American Chemical Society·Paul M LevineMatthew R Pratt

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
ELISA

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.